Cure51
France
- Paris
- 20/03/2024
- Seed
- $16,260,975
The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer.
- Industry Biotechnology Research
- Website https://www.cure51.com/
- LinkedIn https://www.linkedin.com/company/cure51/
Related People
Nicolas WolikowFounder
France -
Greater Paris Metropolitan Region
Over 20 years operating as a Managing Director and revenue generation, digital business development and strategic leadership experiences within start-up and multinational firms.
Forward-thinking executive with a strong ability to lead and motivate worldwide teams comprising of more than 400 employees.
Managing P&L for business divisions exceeding $200M revenue.
Have been Chief Executive Officer, responsible for strategy implementation, business development and acquisitions initiatives. Currently Chief Digital Officer to transform a large organisation. Passionate about product innovations that shape new customer experiences.
FYLD | $41,000,000 | (Feb 18, 2026)
The Compression Company | $3,400,000 | (Feb 18, 2026)
Helia Care, Inc. | $3,000,000 | (Feb 18, 2026)
Dataro | $14,280,000 | (Feb 18, 2026)
Daffodil Health Corp | $16,300,000 | (Feb 18, 2026)
Sphinx(US) | $7,100,000 | (Feb 18, 2026)
Autosana (YC S25) | $3,200,000 | (Feb 18, 2026)
Tangible | $4,300,000 | (Feb 18, 2026)
Certivo | $4,000,000 | (Feb 18, 2026)
GelMEDIX | $13,000,000 | (Feb 18, 2026)
QuadSci.ai | $8,000,000 | (Feb 18, 2026)
Breaker | $6,000,000 | (Feb 18, 2026)
Bland Company | $2,670,000 | (Feb 18, 2026)